AI ultrasound aims to slash maternal deaths in ethiopia
NCT ID NCT07171086
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether portable AI-driven ultrasound devices can help frontline health workers in rural Ethiopia detect pregnancy complications early. About 1,059 pregnant women will be split into three groups: two using different AI ultrasound tools and one receiving standard care without ultrasound. The goal is to see if AI-POCUS reduces maternal deaths, stillbirths, and preterm births.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-POCUS ultrasound devices (BabyChecker and Edan)
What this could lead to
If successful, this could show that AI-assisted ultrasound by frontline health workers reduces maternal and newborn deaths in low-resource settings.
What could go wrong
This is a Phase 4 trial in a specific rural setting, so results may not apply elsewhere. The AI devices may not perform as well as expected, and training or technical issues could limit effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hakim Gizaw Hospital
Debre Berhan, Amhara, 1000, Ethiopia
Contact Phone: •••-•••-•••• Email: •••••@•••••